EXEL vs RVMD
Exelixis, Inc. - Common Stock · Revolution Medicines, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | EXEL | RVMD |
|---|---|---|
| Price | $60.99 | $193.52 |
| Market Cap | $15.11B | $41.48B |
| P/E | 19.31 | — |
| P/B | 8.20 | 15.92 |
| P/S | 6.51 | — |
| ROE | 42.4% | -43.4% |
| Net Margin | 33.7% | — |
| Gross Margin | — | — |
| Revenue Growth | 7.0% | — |
| Dividend Yield | — | — |
| EPS | $3.16 | -$5.28 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.